Rohan Hockings
Follow
Get notifications in MyBN when activity occurs.
Rohan Hockings
Chief Executive, Executive Director / PYC Therapeutics
Dr Rohan Hockings manages a special purpose acquisition fund within the health care sector. Prior to undertaking this role, he has worked in a global management consulting firm, within the equity capital markets team at a national law firm and as a medical practitioner. He has a strong interest in both venture capital and private equity, and the role of each in the delivery of better health outcomes.
In 2022, Mr Hockings was a recipient of the Business News 40under40 Awards, a finalist in its First Amongst Equals category, and winner of the medium-sized business category his work in leading PYC Therapeutics to developing precision medications for retinitis pigmentosa and other eye diseases.
In 2022, Mr Hockings was a recipient of the Business News 40under40 Awards, a finalist in its First Amongst Equals category, and winner of the medium-sized business category his work in leading PYC Therapeutics to developing precision medications for retinitis pigmentosa and other eye diseases.
Lists and Charts
40under40 Award Winner 2022
All 40under40 winners for 2022
| Name | Current company |
|---|
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 367th | Advanced Braking Technology | 23% | 29% |
| 636th | PYC Therapeutics | 3% | 27% |
| 806th | DTI Group | -5% | -15% |
| 1278th | K2fly | -37% | -8% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 87th |  | PYC Therapeutics | $15.8m |
| 90th |  | GreenHy2 | $15.0m |
| 91st | | K2fly | $14.8m |
| 93rd | | Advanced Braking Technology | $14.7m |
| 94th | | DTI Group | $13.3m |
202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in PYC taps investors for $75m | 14 Mar 2024 |
| NEWS: Tagged in Perth biotech company raises $30m | 11 May 2023 |
| REMUNERATION UPDATE: Chief Executive, Executive Director, PYC Therapeutics | 02 Nov 2020 |
| REMUNERATION UPDATE: Chief Executive, Executive Director, PYC Therapeutics | 24 Aug 2020 |
| NEW ROLE: Chief Strategy Officer, PYC Therapeutics | 19 Aug 2020 |
| REMUNERATION UPDATE: Chief Executive, Executive Director, PYC Therapeutics | 30 Jun 2020 |
